Simard Julia F, Arkema Elizabeth V, Nguyen Cathina, Svenungsson Elisabet, Wikström Anna-Karin, Palmsten Kristin, Salmon Jane E
Division of Epidemiology, Department of Health Research and Policy, Stanford School of Medicine, Stanford, CA.
Division of Immunology and Rheumatology, Department of Medicine, Stanford School of Medicine, Stanford, CA.
Paediatr Perinat Epidemiol. 2017 Jan;31(1):29-36. doi: 10.1111/ppe.12332. Epub 2016 Dec 12.
Systemic lupus erythematosus (SLE) is a chronic systemic autoimmune disease that occurs during childbearing years and has been associated with preeclampsia. However, little is known about preeclampsia of early onset, which is associated with severe adverse maternal and perinatal outcomes.
Using national population-based Swedish registers we identified women with SLE (≥2 visits with corresponding ICD codes) and a sample without SLE who gave birth to singleton infants 2001-12. Risk ratios (RR) and 95% confidence intervals (CI) for early-onset preeclampsia (defined by ICD codes corresponding to preeclampsia registered at <34 weeks) in SLE women were calculated based on adjusted modified Poisson models for first, subsequent, and all pregnancies.
Among 742 births to women with SLE and 10 484 births to non-SLE women, there were 32 (4.3%) and 55 (0.5%) diagnoses of early-onset preeclampsia respectively. SLE was associated with an increased risk of early-onset preeclampsia (RR 7.8, 95% CI 4.8, 12.9, all pregnancies). The association remained similar upon restriction to women without pregestational hypertension. Adjustment for antiphospholipid syndrome (APS)-proxy attenuated the association. RRs for early-onset preeclampsia were smaller for subsequent pregnancies (RR 4.7, 95% CI 2.0, 11.2) compared to first and all (see above).
Women with SLE are at increased risk of early-onset preeclampsia and this increased risk may be independent of the traditional risk factors such as pregestational hypertension, APS, BMI, or smoking. Women with SLE during pregnancy should be closely monitored for early-onset preeclampsia and future research needs to identify the non-traditional preeclampsia factors that might cause this serious outcome.
系统性红斑狼疮(SLE)是一种发生于育龄期的慢性全身性自身免疫性疾病,且与子痫前期有关。然而,对于与严重不良孕产妇和围产期结局相关的早发型子痫前期却知之甚少。
利用瑞典全国基于人群的登记资料,我们确定了患有SLE(≥2次就诊且有相应国际疾病分类代码)的妇女以及一个未患SLE的样本,这些妇女在2001年至2012年期间分娩了单胎婴儿。基于调整后的改良泊松模型,计算SLE妇女早发型子痫前期(根据<34周登记的子痫前期相应国际疾病分类代码定义)在首次、后续及所有妊娠中的风险比(RR)和95%置信区间(CI)。
在742例SLE妇女分娩和10484例非SLE妇女分娩中,分别有32例(4.3%)和55例(0.5%)被诊断为早发型子痫前期。SLE与早发型子痫前期风险增加相关(RR 7.8,95% CI 4.8,12.9,所有妊娠)。在排除孕前高血压妇女后,这种关联仍然相似。对抗磷脂综合征(APS)替代指标进行调整后,该关联减弱。与首次及所有妊娠相比,后续妊娠早发型子痫前期的RR较小(RR 4.7,95% CI 2.0,11.2)(见上文)。
SLE妇女早发型子痫前期风险增加,且这种增加的风险可能独立于孕前高血压、APS、体重指数或吸烟等传统风险因素。孕期患有SLE的妇女应密切监测早发型子痫前期,未来研究需要确定可能导致这一严重结局的非传统子痫前期因素。